HLA ASSOCIATION OF ANTI-RO60 AND ANTI-RO52 ANTIBODIES IN SJOGRENS-SYNDROME

被引:20
|
作者
RICCHIUTI, V
ISENBERG, D
MULLER, S
机构
[1] INST BIOL MOLEC & CELLULAIRE, DEPT IMMUNOCHEM, CNRS, UPR 9021, F-67084 STRASBOURG, FRANCE
[2] UCL, DEPT MED, BLOOMSBURY RHEUMATOL UNIT, LONDON, ENGLAND
关键词
D O I
10.1006/jaut.1994.1045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The possible pathological role of antibody subsets specific for different regions of 60-KD and 52-KD Ro/SSA proteins (Ro60 and Ro52) and La protein is unclear. Previously, we have shown that in patients with Sjogren's syndrome, the fine specificity of Ro60 and Ro52 antibodies, as characterized with synthetic peptides, varied considerably according to the origin of sera. We therefore looked for possible associations of HLA class I and class II alleles with Ro and La IgG antibodies in patients with primary Sjogren's syndrome (n=24) and secondary Sjogren's syndrome associated with systemic lupus erythematosus (n=25). Ro60 and Ro52 antibodies were tested by ELISA with the complete parent proteins and with 10 to 24 residue-long peptides of these proteins. Anti-Ro60 antibodies were more frequent in DR3-positive patients and in DQ1-negative patients whereas the presence of Ro52 and La IgG antibodies was significantly increased in patients with A1/B8/DR3 haplotype. Certain HLA associations observed with antibodies reacting with the whole Ro52 protein were not found with antibodies reacting with certain Ro60 and Ro52 peptides and, reciprocally, certain anti-peptide antibodies were linked to particular haplotypes whereas antibodies to the respective parent proteins were not linked to these haplotypes. Thus the production of antibody subsets reacting with different parts or presentations of Ro proteins is, at least in part, influenced immunologically by different HLA haplotypes, and this predisposition may play a role in the pathological development of the disease.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 50 条
  • [1] Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations
    Zampeli, E.
    Mavrommati, M.
    Moutsopoulos, H. M.
    Skopouli, F. N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (04) : S134 - S141
  • [2] Salivary anti-Ro60 and anti-Ro52 Antibody Profiles to Diagnose Sjogren's Syndrome
    Ching, K. H.
    Burbelo, P. D.
    Gonzalez-Begne, M.
    Roberts, M. E. P.
    Coca, A.
    Sanz, I.
    Iadarola, M. J.
    JOURNAL OF DENTAL RESEARCH, 2011, 90 (04) : 445 - 449
  • [3] Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain
    Menor Almagro, Raul
    Jurado Roger, Aurora
    Rodriguez Gutierrez, Francisco Javier
    Solis Diaz, Rocio
    Humberto Cardiel, Mario
    Salaberri Maestrojuan, Jose Javier
    REUMATOLOGIA CLINICA, 2016, 12 (05): : 256 - 262
  • [4] Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis
    Gkoutzourelas, Athanasios
    Liaskos, Christos
    Mytilinaiou, Maria G.
    Simopoulou, Theodora
    Katsiari, Christina
    Tsirogianni, Alexandra
    Daoussis, Dimitrios
    Scheper, Thomas
    Meyer, Wolfgang
    Bogdanos, Dimitrios P.
    Sakkas, Lazaros I.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] The implication of anti-Ro60 with or without anti-Ro52 antibody in patients with systemic lupus erythematosus
    Liao, Katie
    Li, Ning
    Bonin, Julie
    Koelmeyer, Rachel
    Kent, Joanna
    Pellicano, Rebecca
    De Silva, Thilinie
    Yap, Kristy
    Golder, Vera
    Kitching, A. Richard
    Morand, Eric F.
    Hoi, Alberta
    RHEUMATOLOGY, 2024,
  • [6] ANTI-RO60 SEROPOSITIVITY DETERMINES EPITOPE SPECIFICITY OF ANTI-RO52 ANTIBODIES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC AND MALIGNANT DISEASES
    Gkoutzourelas, A.
    Liaskos, C.
    Papadopoulos, V.
    Mytilinaiou, M. G.
    Christina, K.
    Scheper, T.
    Meyer, W.
    Bogdanos, D. P.
    Papandreou, C.
    Sakkas, L. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1692 - 1692
  • [7] Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis
    Ogawa-Momohara, Mariko
    Muro, Yoshinao
    Mitsuma, Teruyuki
    Katayama, Masao
    Yanaba, Koichi
    Nara, Mizuho
    Kakeda, Masato
    Akiyama, Masashi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2019, 96 (01) : 50 - 52
  • [8] Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome
    Yamaguchi, Koichi
    Tang, Qi
    Poland, Paul
    Reay, Daniel P.
    Gregory, Alyssa
    Aggarwal, Rohit
    Oddis, Chester V.
    Ascherman, Dana P.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases
    Lee, Adrian Y. S.
    Reed, Joanne H.
    Gordon, Tom P.
    JOURNAL OF AUTOIMMUNITY, 2021, 124
  • [10] Anti-Ro52 antibodies, antisynthetase antibodies, and antisynthetase syndrome
    Vidya S. Limaye
    John Cassidy
    Grace Scott
    Peter J. Roberts-Thomson
    David Gillis
    Clinical Rheumatology, 2008, 27 : 521 - 523